Current study was designed to test if MRTF-A is involved in the molecular pathogenesis of AD, using angiotensin II-induced mouse model of AD [13] with genetic deletion [11] or pharmacological inhibition [14] of MRTF-A. Here, AGT is linked to Alzheimer disease.